Rare diseases
Investigational molecules
Locations
7000 Shoreline Court Suite 350, 94080-7604, United States
Research activity is centered on uveal melanoma, with studies addressing both early-stage eye cancer and metastatic disease. The sponsor’s programs include treatment strategies for HLA-A2 negative metastatic cases and disease control in primary ocular tumors.
Key interests include preservation of vision, prevention of enucleation, and tumor control in ocular malignancies.
Ideaya Biosciences Inc. runs clinical trials in conditions such as Uveal melanoma, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
France
BelgiumBelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
